AKT1 and cancer: In many cancers, mutation of ARID1A has been found to co-occur with mutations in the PI3K/AKT pathway (40, 50, 81, 82), among which the coexistence of ARID1A deficiency and phosphatidylinositol 3-hydroxy kinase (PIK3CA) mutation is a more typical phenomena.